- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-1-1-mer
- Ligands
- 7 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN.2: 7 residues within 4Å:- Chain A: E.213, V.256, L.263, N.264, V.446, S.447
- Ligands: NAG.14
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:V.446
- Hydrogen bonds: A:V.446
NAG-NAG-BMA-MAN.6: 9 residues within 4Å:- Chain C: E.213, V.256, L.263, N.264, G.380, C.445, V.446, S.447
- Ligands: NAG.36
3 PLIP interactions:3 interactions with chain C- Hydrophobic interactions: C:V.446
- Hydrogen bonds: C:G.380, C:V.446
NAG-NAG-BMA-MAN.9: 11 residues within 4Å:- Chain E: E.213, P.214, V.256, L.263, N.264, G.380, R.444, C.445, V.446, S.447
- Ligands: NAG.54
3 PLIP interactions:3 interactions with chain E- Hydrophobic interactions: E:V.446
- Hydrogen bonds: E:G.380, E:V.446
- 52 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.11: 3 residues within 4Å:- Chain A: S.389, G.390, N.393
Ligand excluded by PLIPNAG.12: 4 residues within 4Å:- Chain A: N.340, E.341, T.395, W.396
Ligand excluded by PLIPNAG.13: 5 residues within 4Å:- Chain A: N.297, T.299, H.331, N.333, R.444
Ligand excluded by PLIPNAG.14: 4 residues within 4Å:- Chain A: V.446, S.447, N.448
- Ligands: NAG-NAG-BMA-MAN.2
Ligand excluded by PLIPNAG.15: 3 residues within 4Å:- Chain A: N.135, G.146, K.149
Ligand excluded by PLIPNAG.16: 3 residues within 4Å:- Chain A: N.139, I.140, D.326
Ligand excluded by PLIPNAG.17: 4 residues within 4Å:- Chain A: Q.132, S.152, F.153, N.154
Ligand excluded by PLIPNAG.18: 4 residues within 4Å:- Chain A: N.199, T.200
- Chain E: R.310, W.316
Ligand excluded by PLIPNAG.19: 4 residues within 4Å:- Chain A: N.236, G.237, T.238, S.276
Ligand excluded by PLIPNAG.20: 1 residues within 4Å:- Chain A: N.90
Ligand excluded by PLIPNAG.21: 5 residues within 4Å:- Chain A: E.269, E.270, N.291, E.292, K.345
Ligand excluded by PLIPNAG.22: 1 residues within 4Å:- Chain A: N.356
Ligand excluded by PLIPNAG.23: 3 residues within 4Å:- Chain A: K.233, T.242, N.243
Ligand excluded by PLIPNAG.24: 3 residues within 4Å:- Chain A: N.278, T.280, N.281
Ligand excluded by PLIPNAG.25: 3 residues within 4Å:- Chain A: N.303, I.324, V.442
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain A: Q.295, N.297, N.333
Ligand excluded by PLIPNAG.27: 2 residues within 4Å:- Chain B: S.117, N.118
Ligand excluded by PLIPNAG.28: 2 residues within 4Å:- Chain B: N.99, E.102
Ligand excluded by PLIPNAG.29: 7 residues within 4Å:- Chain C: N.236, T.238, S.276, E.277, N.278, I.279
- Ligands: NAG.31
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain C: D.232, T.242, N.243
Ligand excluded by PLIPNAG.31: 4 residues within 4Å:- Chain C: N.278, I.279, T.280
- Ligands: NAG.29
Ligand excluded by PLIPNAG.32: 3 residues within 4Å:- Chain C: S.389, G.390, N.393
Ligand excluded by PLIPNAG.33: 3 residues within 4Å:- Chain C: N.340, E.341, W.396
Ligand excluded by PLIPNAG.34: 4 residues within 4Å:- Chain C: N.297, T.299, H.331, N.333
Ligand excluded by PLIPNAG.35: 4 residues within 4Å:- Chain C: Q.295, N.297, N.333, S.335
Ligand excluded by PLIPNAG.36: 4 residues within 4Å:- Chain C: V.446, S.447, N.448
- Ligands: NAG-NAG-BMA-MAN.6
Ligand excluded by PLIPNAG.37: 3 residues within 4Å:- Chain C: N.303, I.324, V.442
Ligand excluded by PLIPNAG.38: 5 residues within 4Å:- Chain C: Q.132, S.152, F.153, N.154, K.165
Ligand excluded by PLIPNAG.39: 4 residues within 4Å:- Chain A: R.310
- Chain C: R.194, N.199, T.200
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain C: N.135, K.149
Ligand excluded by PLIPNAG.41: 1 residues within 4Å:- Chain C: N.356
Ligand excluded by PLIPNAG.42: 5 residues within 4Å:- Chain C: E.270, E.271, N.291, K.345, Q.349
Ligand excluded by PLIPNAG.43: 3 residues within 4Å:- Chain C: E.89, N.90
- Chain D: T.10
Ligand excluded by PLIPNAG.44: 4 residues within 4Å:- Chain D: N.92, T.94, W.95, Y.119
Ligand excluded by PLIPNAG.45: 1 residues within 4Å:- Chain D: N.118
Ligand excluded by PLIPNAG.46: 4 residues within 4Å:- Chain E: E.89, N.90
- Chain F: G.8, S.9
Ligand excluded by PLIPNAG.47: 7 residues within 4Å:- Chain E: N.236, T.238, G.239, P.240, S.276, E.277, I.279
Ligand excluded by PLIPNAG.48: 2 residues within 4Å:- Chain E: D.232, N.243
Ligand excluded by PLIPNAG.49: 3 residues within 4Å:- Chain E: N.278, I.279, T.280
Ligand excluded by PLIPNAG.50: 2 residues within 4Å:- Chain E: G.390, N.393
Ligand excluded by PLIPNAG.51: 2 residues within 4Å:- Chain E: N.340, W.396
Ligand excluded by PLIPNAG.52: 5 residues within 4Å:- Chain E: N.297, T.299, H.331, N.333, T.415
Ligand excluded by PLIPNAG.53: 4 residues within 4Å:- Chain E: Q.295, N.297, N.333, R.444
Ligand excluded by PLIPNAG.54: 3 residues within 4Å:- Chain E: N.264, N.448
- Ligands: NAG-NAG-BMA-MAN.9
Ligand excluded by PLIPNAG.55: 3 residues within 4Å:- Chain E: N.303, I.324, V.442
Ligand excluded by PLIPNAG.56: 4 residues within 4Å:- Chain E: Q.132, S.152, F.153, N.154
Ligand excluded by PLIPNAG.57: 4 residues within 4Å:- Chain C: R.310
- Chain E: R.194, N.199, T.200
Ligand excluded by PLIPNAG.58: 3 residues within 4Å:- Chain E: T.134, N.135, T.137
Ligand excluded by PLIPNAG.59: 2 residues within 4Å:- Chain E: G.355, N.356
Ligand excluded by PLIPNAG.60: 3 residues within 4Å:- Chain E: E.270, E.271, N.291
Ligand excluded by PLIPNAG.61: 3 residues within 4Å:- Chain F: N.99, S.101, E.102
Ligand excluded by PLIPNAG.62: 2 residues within 4Å:- Chain F: N.92, T.94
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Antanasijevic, A. et al., Polyclonal antibody responses to HIV Env immunogens resolved using cryoEM. Nat Commun (2021)
- Release Date
- 2021-08-04
- Peptides
- BG505 SOSIP.v5.2 N241/N289 - gp120: ACE
BG505 SOSIP.v5.2 N241/N289 - gp41: BDF
Rh.33311 pAbC-8 - Heavy Chain: G
Rh.33311 pAbC-8 - Light Chain: H - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CE
EB
BD
DF
FG
HH
L
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-1-1-mer
- Ligands
- 7 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 52 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Antanasijevic, A. et al., Polyclonal antibody responses to HIV Env immunogens resolved using cryoEM. Nat Commun (2021)
- Release Date
- 2021-08-04
- Peptides
- BG505 SOSIP.v5.2 N241/N289 - gp120: ACE
BG505 SOSIP.v5.2 N241/N289 - gp41: BDF
Rh.33311 pAbC-8 - Heavy Chain: G
Rh.33311 pAbC-8 - Light Chain: H - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CE
EB
BD
DF
FG
HH
L